Business Context and Reporting Period
Company: NOVA LTD. (Nasdaq: NVMI)
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: Fourth Quarter and Full Year ended December 31, 2021
Filing Date: February 24, 2022
Business Overview: Nova is a leading provider of material, optical, and chemical metrology solutions for advanced process control in semiconductor manufacturing. The company recently expanded its portfolio through the acquisition of ancosys, a German metrology supplier.
Key Financial Metrics
Revenue and Profitability
| Metric | Q4 2021 | Q4 2020 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Total Revenue | $121.5 million | $76.3 million | $416.1 million | $269.4 million |
| GAAP Net Income | $22.2 million | $13.7 million | $93.1 million | $47.9 million |
| Non-GAAP Net Income | $32.8 million | $15.9 million | $114.7 million | $59.6 million |
| GAAP EPS (Diluted) | $0.73 | $0.47 | $3.12 | $1.65 |
| Non-GAAP EPS (Diluted) | $1.08 | $0.55 | $3.85 | $2.06 |
| Gross Margin (GAAP) | 56% | 55% | 57% | 57% |
| Operating Expenses | $38.4 million | $25.5 million | $125.0 million | $97.4 million |
Liquidity and Balance Sheet
- Cash and Cash Equivalents (Dec 31, 2021): $126.7 million
- Short-term Interest-bearing Deposits: $221.9 million
- Marketable Securities: $199.0 million (Total: $61.6M current + $137.4M non-current)
- Convertible Senior Notes (Current Liability): $183.0 million (reclassified from non-current in 2020)
- Total Assets: $805.2 million (up from $655.8 million in 2020)
Cash Flow
- Net Cash Provided by Operating Activities (FY 2021): $132.3 million
- Net Cash Used in Investing Activities (FY 2021): $(238.5) million (primarily due to investment in marketable securities)
- Net Cash Provided by Financing Activities (FY 2021): $11 thousand
Material Changes vs. Prior Period
- Revenue Growth: Q4 2021 revenue increased 59% year-over-year (YoY) and 8% quarter-over-quarter (QoQ). Full-year 2021 revenue grew 54% YoY.
- Profitability Expansion: GAAP net income grew 63% in Q4 and 94% for the full year compared to 2020. Non-GAAP net income grew 106% in Q4 and 93% for the full year.
- Operating Expenses: Increased significantly in Q4 ($38.4M vs $25.5M in Q4 2020) and FY 2021 ($125M vs $97.4M in FY 2020), driven by higher R&D, sales, and marketing spend, as well as acquisition-related expenses.
- Balance Sheet Shift: Convertible senior notes were reclassified from non-current to current liabilities, reflecting a change in classification rather than new debt issuance in the period.
- Product Launches: Recognized revenue from multiple customers for the new Nova METRION materials metrology solution and secured orders for VERAFLEX IV.
Guidance, Outlook, and Risks
Q1 2022 Financial Outlook
Management expects the following for the quarter ending March 31, 2022:
- Revenue: $122 million to $132 million
- GAAP Diluted EPS: $0.78 to $0.96
- Non-GAAP Diluted EPS: $0.96 to $1.14
Management Commentary
CEO Eitan Oppenhaim highlighted strong operational agility despite pandemic-related supply chain challenges. The acquisition of ancosys is expected to extend available markets and drive growth in 2022.
Risks and Contingencies
- Supply Chain: Ongoing influence of the pandemic on global supply chains.
- Customer Concentration: Dependency on a small number of large customers.
- Geopolitical: Political, economic, and military instability in Israel.
- Integration: Risks associated with integrating current or future acquisitions (e.g., ancosys).
- Market Volatility: Difficulty predicting market downturns or expansions in the semiconductor industry.
Investor Verification Checklist
- Debt Classification: Verify the impact of the $183 million convertible senior notes reclassification from non-current to current liabilities on liquidity ratios.
- Acquisition Integration: Monitor the financial contribution and integration progress of the ancosys acquisition.
- Non-GAAP Adjustments: Review the reconciliation of GAAP to Non-GAAP results, specifically the $3.7 million tax benefit attributed to a one-time elective tax settlement in Q4 2021.
- Inventory Levels: Note the increase in inventory to $78.7 million (from $61.7 million in 2020) and assess potential obsolescence risks given supply chain constraints.
- Guidance Execution: Track Q1 2022 revenue and EPS performance against the provided ranges ($122M-$132M revenue; $0.78-$0.96 GAAP EPS).